The proteasome subunit PSMA7 located on the 20q13 amplicon is overexpressed and associated with liver metastasis in colorectal cancer

Oncology Reports

Volumn 19, Issue 2, 2008, Pages 441-446

  Hu, Xiao Tong ^a,b   Chen, Wei ^a   Wang, Da ^a,b   Shi, Qing Lan ^a,b   Zhang, Fu Biao ^a,b   Liao, Yong Qiang ^a   Jin, Mei ^a   He, Chao ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Key Laboratory of Biotherapy of Zhejiang Province   (China)

Author keywords

20q13 amplicon; Colorectal cancer; Immunohistochemistry; Metastasis; PSMA7

Indexed keywords

MESSENGER RNA; PROTEASOME; PROTEIN PSMA7; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ADULT; AGED; AMPLICON; ARTICLE; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME 20Q; COLON ADENOCARCINOMA; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RECTUM CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 38749133288     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.2.441     Document Type: Article

References (33)

1. Gutman M and Fidler IJ: Biology of human colon cancer metastasis. World J Surg 19: 226-234, 1995.
2. Meijer GA, Hermsen MA, Baak JP, et al: Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 51: 901-909, 1998.
3. Ried T, Knutzen R, Steinbeck R, et al: Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15: 234-245, 1996.
4. Schlegel J, Stumm G, Scherthan H, Bocker, T, Zirngibl H, Ruschoff J and Hofstadter F: Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res 55: 6002-6005, 1995.
5. Tsafrir D, Bacolod M, Selvanayagam Z, et al: Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66: 2129-2137, 2006.
6. Hershko A: Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol 9: 788-799, 1997.
7. Kloetzel PM: Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat Immunol 5: 661-669, 2004.
8. Varshavsky A: The N-end rule and regulation of apoptosis. Nat Cell Biol 15: 373-376, 2003.
9. Deveraux Q, Ustrell V, Pickart C and Rechsteiner M: A 26S protease subunit that binds ubiquitin conjugates. J Biol Chem 269: 7059-7061, 1994.
10. Hough R, Pratt G and Rechsteiner M: Purification of two high molecular weight proteases from rabbit reticulocyte lysate. J Biol Chem 262: 8303-8313, 1987.
11. Orlowski M and Wilk S: Catalytic activities of the 20S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys 383: 1-16, 2000.
12. Baumeister W, Walz J, Zuhl F and Seemuller E: The proteasome: paradigm of a self-compartmentalizing protease. Cell 92: 367-380, 1998.
13. Pickart CM and Cohen RE: Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol 5: 177-187, 2004.
14. Ciechanover A, Laszlo A, Bercovich B, Stancovski I, Alkalay I, Ben-Neriah Y and Orian A: The ubiquitin-mediated proteolytic system: involvement of molecular chaperones, degradation of oncoproteins, and activation of transcriptional regulators. Cold Spring Harb Symp Quant Biol 60: 491-501, 1995.
15. Spataro V, Norbury C and Harris AL: The ubiquitin-proteasome pathway in cancer. Br J Cancer 77: 448-455, 1998.
16. Huang J, Kwong J, Sun EC and Liang TJ: Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol 70: 5582-5591, 1996.
17. Kumatori A, Tanaka K, Inamura N, et al: Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci USA 87: 7071-7075, 1990.
18. Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL and Liang TJ: Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol 73: 7231-7240, 1999.
19. Zhang Z, Torii N, Furusaka A, Malayaman N, Hu Z and Liang TJ: Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem 275: 15157-15165, 2000.
20. Ryo A, Suzuki Y, Arai M, et al: Identification and characterization of differentially expressed mRNAs in HIV type 1-infected human T cells. AIDS Res Hum Retroviruses 16: 995-1005, 2000.
21. Kruger M, Beger C, Welch PJ, Barber JR, Manns MP and Wong-Staal F: Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. Mol Cell Biol 21: 8357-8364, 2001.
22. Cho S, Choi YJ, Kim JM, Jeong ST, Kim JH, Kim SH and Ryu SE: Binding and regulation of HIF-1alpha by a subunit of the proteasome complex, PSMA7. FEBS Lett 498: 62-66, 2001.
23. Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578, 1999.
24. Pickart CM: Ubiquitin enters the new millennium. Mol Cell 8: 499-504, 2001.
25. Shenoy SK, McDonald PH, Kohout TA and Lefkowitz RJ: Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294: 1307-1313, 2001.
26. Yu A and Malek TR: The proteasome regulates receptor-mediated endocytosis of interleukin-2. J Biol Chem 276: 381-385, 2001.
27. Ferdous A, Gonzalez F, Sun L, Kodadek T and Johnston SA: The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol Cell 7: 981-991, 2001.
28. Gillette TG, Huang W, Russell SJ, Reed SH, Johnston SA and Friedberg EC: The 19S complex of the proteasome regulates nucleotide excision repair in yeast. Genes Dev 15: 1528-1539, 2001.
29. Lommel L, Chen L, Madura K and Sweder K: The 26S proteasome negatively regulates the level of overall genomic nucleotide excision repair. Nucleic Acids Res 28: 4839-4845, 2000.
30. Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL and Chang C: Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J Biol Chem 277: 36570-36576, 2002.
31. Ohnami S, Matsumoto N, Nakano M, et al: Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity. Cancer Res 59: 5565-5571, 1999.
32. Touitou R, Richardson J, Bose S, Nakanishi M, Rivett J and Allday MJ: A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J 20: 2367-2375, 2001.
33. Hougardy BM, Maduro JH, van der Zee AG, de Groot DJ, van den Heuvel FA, de Vries EG and de Jong S: Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis. Int J Cancer 118: 1892-1900, 2006.